Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report

M Brunet, T Van Gelder, A Åsberg… - Therapeutic drug …, 2019 - journals.lww.com
Ten years ago, a consensus report on the optimization of tacrolimus was published in this
journal. In 2017, the Immunosuppressive Drugs Scientific Committee of the International …

NFAT control of innate immunity

J Fric, T Zelante, AYW Wong, A Mertes… - Blood, The Journal …, 2012 - ashpublications.org
The calcineurin/nuclear factor of activated T cells (NFAT) signaling pathway mediates
multiple adaptive T-cell functions, but recent studies have shown that calcineurin/NFAT …

Defective localization with impaired tumor cytotoxicity contributes to the immune escape of NK cells in pancreatic cancer patients

SA Lim, J Kim, S Jeon, MH Shin, J Kwon… - Frontiers in …, 2019 - frontiersin.org
Tumor-infiltrating lymphocytes (TILs), found in patients with advanced pancreatic ductal
adenocarcinoma (PDAC), are shown to correlate with overall survival (OS) rate. Although …

Clinical relevance of natural killer cells following hematopoietic stem cell transplantation

JM Palmer, K Rajasekaran, MS Thakar… - Journal of …, 2012 - pmc.ncbi.nlm.nih.gov
Natural killer (NK) cells are one of the first cells to recover following allogeneic
hematopoietic stem cell transplantation (HSCT), and are believed to play an important role …

Hypoxia-driven HIF-1α activation reprograms pre-activated NK cells towards highly potent effector phenotypes via ERK/STAT3 pathways

SA Lim, Y Moon, MH Shin, TJ Kim, S Chae, C Yee… - Cancers, 2021 - mdpi.com
Simple Summary In patients with advanced cancer, hypoxic stress shapes NK cells toward
tumor-resistant and immunosuppressive phenotypes. Therefore, a strategy to restore NK cell …

Small-Molecule Immunosuppressive Drugs and Therapeutic Immunoglobulins Differentially Inhibit NK Cell Effector Functions in vitro

A Pradier, M Papaserafeim, N Li, A Rietveld… - Frontiers in …, 2019 - frontiersin.org
Small-molecule immunosuppressive drugs (ISD) prevent graft rejection mainly by inhibiting
T lymphocytes. Therapeutic immunoglobulins (IVIg) are used for substitution, antibody …

Ex Vivo Expansion of Highly Cytotoxic Human NK Cells by Cocultivation with Irradiated Tumor Cells for Adoptive Immunotherapy

SA Lim, TJ Kim, JE Lee, CH Sonn, K Kim, J Kim… - Cancer research, 2013 - AACR
Adoptive natural killer (NK) cell therapy may offer an effective treatment regimen for cancer
patients whose disease is refractory to conventional therapy. NK cells can kill a wide range …

Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR NK Cells and Contributes to Suboptimal Control of …

JKP Lam, T Azzi, KF Hui, AMG Wong… - Frontiers in …, 2020 - frontiersin.org
Post-transplant lymphoproliferative disorder (PTLD) is a rare but potentially life-threatening
complication, frequently associated with Epstein-Barr virus (EBV), which develops after solid …

The peripheral NK cell repertoire after kidney transplantation is modulated by different immunosuppressive drugs

C Neudoerfl, BJ Mueller, C Blume, K Daemen… - Frontiers in …, 2013 - frontiersin.org
In the context of kidney transplantation, little is known about the involvement of natural killer
(NK) cells in the immune reaction leading to either rejection or immunological tolerance …

Examining the impact of immunosuppressive drugs on antibody-dependent cellular cytotoxicity (ADCC) of human peripheral blood natural killer (NK) cells and gamma …

S Jalali, S Stankovic, GP Westall, PC Reading… - Transplant …, 2024 - Elsevier
Background Human natural killer (NK) cells and gamma delta (γδ) T cells may impact
outcomes of solid organ transplantation (SOT) such as lung transplantation (LTx) following …